Catinazzo Thomasinsider trades
In SEC Form 4 filings, Catinazzo Thomas is listed as Chief Financial Officer of Relay Therapeutics, Inc. (RLAY). In the last 90 days, Catinazzo Thomas sold $664.9K of Relay Therapeutics, Inc. (RLAY) on the open market and bought none. All 3 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| RLAYRelay Therapeutics, Inc. | Chief Financial Officer | 3 | Oct 8 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-09
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| RLAYRelay Therapeutics, Inc. | Oct 6 | Oct 8 | S | 17,511 | $18.58 | Sale −$325,354 | 105,340 | Yes | Form 4 |
| RLAYRelay Therapeutics, Inc. | Oct 6 | Oct 8 | S | 206 | $19.26 | Sale −$3,968 | 105,134 | Yes | Form 4 |
| RLAYRelay Therapeutics, Inc. | Sep 8 | Sep 9 | S | 17,717 | $18.94 | Sale −$335,560 | 122,851 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.